Mangoceuticals (MGRX) Change in Accured Expenses (2023 - 2026)
Mangoceuticals' (MGRX) quarterly Change in Accured Expenses came in at -$9191.0 in Q1 2026, down 102.7% year-on-year from $340678.0 in Q1 2025, and up 90.64% quarter-over-quarter from -$98169.0 in Q4 2025.
Mangoceuticals (MGRX) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Mangoceuticals has disclosed Change in Accured Expenses across 4 years of filings, most recently posting -$9191.0 for Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$9191.0, down 102.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$294200.0 (down 205.57% YoY), and the FY2025 annual result was $55669.0, up 306.18% from the prior year.
- Change in Accured Expenses came in at -$9191.0 for Q1 2026 at Mangoceuticals, up from -$98169.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $542885.0 in Q2 2024 to a low of -$593754.0 in Q4 2024.
- The 4-year median for Change in Accured Expenses is -$9191.0 (2026), against an average of $9736.0.
- Peak annual rise in Change in Accured Expenses reached 873.37% in 2025, while the deepest fall reached 2385.46% in 2025.
- Mangoceuticals' Change in Accured Expenses stood at $51706.0 in 2023, then plunged by 1248.33% to -$593754.0 in 2024, then surged by 83.47% to -$98169.0 in 2025, then soared by 90.64% to -$9191.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$9191.0 (Q1 2026), -$98169.0 (Q4 2025), and -$276656.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 8.92 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 11.03 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | -873,000.00 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -20.60 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -6.14 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | -35.25 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | -9.67 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 49.11 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | -10.77 Mn |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | -9,191.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,191.00 |
| Mar 31, 2026 | -9,191.00 |
| Dec 31, 2025 | -98,169.00 |
| Dec 31, 2025 | -98,169.00 |
| Sep 30, 2025 | -276,656.00 |
| Sep 30, 2025 | -276,656.00 |
| Jun 30, 2025 | 89,816.00 |
| Jun 30, 2025 | 89,816.00 |
| Mar 31, 2025 | 340,678.00 |
| Mar 31, 2025 | 340,678.00 |
| Dec 31, 2024 | -593,754.00 |
| Dec 31, 2024 | -593,754.00 |
| Sep 30, 2024 | -11,131.00 |
| Sep 30, 2024 | -11,131.00 |
| Jun 30, 2024 | 542,885.00 |
| Jun 30, 2024 | 542,885.00 |
| Mar 31, 2024 | 35,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 51,706.00 |
| Dec 31, 2023 | 51,706.00 |